{
    "nct_id": "NCT03471650",
    "official_title": "A Phase II Study to Evaluate the Performance of PSMA-targeted 18F-DCFPyL PET/CT for the Detection of Clinically Significant Prostate Cancer in Men With an Elevated PSA",
    "inclusion_criteria": "* ≥18 years of age\n* PSA of 2-10 ng/mL\n* Clinical stage T1c-T2a on digital rectal exam\n* Elect to undergo TRUS-guided prostate biopsy as part of routine clinical care\n* Willingness to sign informed consent and comply with all protocol requirements\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* History of prior prostate biopsy\n* Administered a radioisotope ≤5 physical half-lives prior to the date of study PET/CT\n* Administered IV X-ray contrast medium ≤24 hours prior to the date of study PET/CT\n* Administered oral contrast medium ≤120 hours prior to the date of study PET/CT\n* Any medical condition or other circumstances that in the opinion of the investigators compromise obtaining reliable data or achieving the study objectives",
    "miscellaneous_criteria": ""
}